Trial ID or NCT#
NCT03486327
Status
Purpose
This is an exploratory, single center, open label, parallel-dose, and prospective study of BR55 CEUS for characterization of solid pancreatic lesions in subjects with suspected PDAC using transabdominal US.
Official Title
Transabdominal Ultrasound With BR55 for Characterization of Pancreatic Lesions
Eligibility Criteria
Ages Eligible for Study: Older than 18 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: No
Investigator(s)
Walter Park
Gastroenterologist,
Pancreas specialist,
Gastrointestinal specialist,
Pancreatologist
Associate Professor of Medicine (Gastroenterology and Hepatology)
Contact us to find out if this trial is right for you.
CONTACT
Mahima Goel
650.723.0371
View on ClinicalTrials.gov